|
(Check one):
|
[X] Form 10-K
|
☐ Form 20-F
|
☐ Form 11-K
|
|
|
|
☐ Form 10-Q
|
☐ Form 10-D
|
☐ Form N-CEN
|
☐ Form N-CSR
|
For Period Ended: December 31, 2025
☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition Report on Form 10-Q
For the Transition Period Ended:
|
Read Instruction (on back page) Before Preparing
Form. Please Print
or Type.
|
| Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
|
| PART I — REGISTRANT INFORMATION |
|
| INTERPARFUMS, INC. |
| Full Name of Registrant |
|
| Former Name if Applicable |
|
| 551 Fifth Avenue |
| Address of Principal Executive Office (Street and Number) |
|
| New York, NY 10176 |
| City, State and Zip Code |
SEC 1344 (01-19) Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.
| Board of Governors of the Federal Reserve System |
OMB Number 7100-0091 |
Approval expires February 28, 2026 |
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| ☒ |
(a) |
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| (b) |
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the
fifth calendar day following the prescribed due date; and
|
| (c) |
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
Interparfums Inc. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Annual Report”) within the time period prescribed because management requires additional time to complete its final evaluation of internal control over financial reporting and to finalize the preparation of the Company’s consolidated financial statements and related disclosures to be included in the 2025 Annual Report. The Company’s independent registered public accounting firm, Forvis Mazars, LLP, also requires more time to complete the necessary procedures to issue its opinions on the consolidated financial statements and the Company’s internal control over financial reporting also to be included in the 2025 Annual Report. The Company expects to file its 2025 Annual Report as soon as practicable, but not later than March 17, 2026, which is the extension period provided by Rule 12b-25 promulgated under the Securities Exchange Act of 1934, as amended.
In connection with the completion of the audit, the Company has evaluated the status of the remediation efforts relating to the material weaknesses in internal control over financial reporting as of December 31, 2024. Although the Company has implemented significant remediation measures and has made substantial progress in strengthening its internal control environment, including enhancements to control documentation, review controls, monitoring activities, personnel training, and Information Technology General Controls, management expects to conclude that one material weakness in internal control over financial reporting continued to exist as of December 31, 2025, as the remediation efforts were not fully completed and/or operating for a sufficient period of time to permit management to conclude that the material weakness has been remediated.
The material weakness is not expected to result in changes to the financial information previously reported by the Company in its press release dated February 24, 2026, which was filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on the same date. The Company does not expect such deficiencies in internal controls will impact the financial results to be included in the 2025 Annual Report.
PART IV — OTHER INFORMATION
| (1) |
Name and telephone number of person to contact in regard to this notification |
| Michel Atwood |
|
212 |
|
983.2640 |
| (Name) |
|
(Area Code) |
|
(Telephone Number) |
| (2) |
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No |
|
|
| (3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? |
|
☐ Yes ☒ No |
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. |
The Company issued its Earnings Release on February 24, 2026. Based on currently available information and subject to Forvis Mazars, LLP’s completion of the necessary procedures to issue its opinions (as described in Part III herein), the Company does not expect any changes to the financial results to be included in the 2025 Annual Report compared to the financial information reported in the Earnings Release.
Forward-Looking Statements
Statements in this document which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate”, “believe”, “could”, “estimate”, "expect”, “intend”, “may”, "should”, “will”, and “would” or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the Company’s ability to file the 2025 Annual Report within the anticipated time period, the Company’s expectations regarding the financial results to be included in the 2025 Annual Report, the material weaknesses identified and any related impacts, and the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in the reports the Company files from time to time with the Securities and Exchange Commission. The Company does not intend to and undertakes no duty to update the information contained in this Form 12b-25.
